OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Endocrinology Diabetes and Obesity is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?	52
Obesity and infertility: a double whammy	40
Updates in thyroid healthcare delivery: advancing patient-centered care	38
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome	33
Advances in assessment and treatment of bone, mineral and parathyroid disorders	32
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health	24
Nutrition and thyroid disease	24
Editorial introduction	24
Editorial introduction	23
Beyond weight loss: tirzepatide as a dual GIP/GLP-1 receptor agonist for obstructive sleep apnea	22
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis	22
Financial toxicity in thyroid cancer survivors	22
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?	21
Recent advances in anaplastic thyroid cancer management	18
Secondary hyperparathyroidism in chronic kidney disease: update on pathophysiology and new treatment targets	18
Interactions between antidiabetes medications and heart–brain axis	18
Preventing type 1 diabetes development and preserving beta-cell function	18
Editorial introduction	18
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency	15
The use of anabolic agents in the treatment of osteoporosis: a clinical update	15
Update on fracture risk assessment in osteoporosis	15
Epidemiologic changes in thyroid disease	14
An update on bone in diabetes	14
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia	14
Fibrous dysplasia in children and its management	14

Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?	14
Assisted reproductive technology outcomes and management considerations for people with epilepsy	13
Precision medicine in diabetes care	13
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks	13
Editorial introductions	12
The uncommon forms of congenital adrenal hyperplasia	12
Editorial introductions	12
Type 2 diabetes: a contemporary view from the Asian lens	12
Hypertriglyceridemia: updates from clinical trials of new agents and real-world registries	12
Glucocorticoid withdrawal syndrome: what to expect and how to manage	11
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease	11
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders	11
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease	11
Editorial introductions	10
An update on investigation and management of renal bone disease	10
A short history of saturated fat: the making and unmaking of a scientific consensus	10
Induction of antigenic immune tolerance to delay type 1 diabetes – challenges for clinical translation	10
Adrenal insufficiency and pregnancy	10
Legislation, medicine, and politics: care for gender diverse youth	10
Editorial introductions	9
Novel techniques for assessment of bone tissue material properties	9
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment	9
Indications for testosterone therapy in men	9
Editorial introductions	9
Microbiome-derived signaling molecules and the brain–gut axis: emerging mechanisms and clinical implications	8
Multifactorial chylomicronemia syndrome	8
The interaction between gut microbiome and bone health	8
The future of triglyceride-regulating therapies and registries	8
Time to cycle regularity and health risks	8
Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective	7
Advanced imaging and theranostics in thyroid cancer	7
Revisiting the relationship between weight loss and bone health in people living with obesity: insights from the latest evidence	7
The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?	7
Type 2 diabetes mellitus and cognitive function: understanding the connections	7
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety	7
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome	6
Bridging the LatinX community care gap	6
When history, law, and medicine intersect	6
The psychosocial impact of thyroid cancer	6
Editorial introductions	6
Radiofrequency ablation (RFA) compared to observation for benign thyroid nodules: emerging considerations for judicious use	6
Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases	6
Current challenges in Cushing's syndrome testing: blood, saliva, urine, or hair?	6
Predictors of cardiovascular risk in familial hypercholesterolemia	6
Can artificial intelligence and wearable technologies transform diabetes foot health?	5
Recent advances in the role of miRNAs in bone disease	5
Preconception health optimization in women with polycystic ovary syndrome − how to find the time?	5
Editorial: New horizons for thyroid diseases: transformative changes and tailored care	5
Testosterone and the prevention of type 2 diabetes mellitus: therapeutic implications from recent trials	5
Fracture prediction tools in diabetes	5

Skeletal health in diabetes	5
Mixed-methods research on androgen abuse – a review	5
Bone marrow adiposity in diabetes and clinical interventions	4
The psychological dimension of obesity – an uncharted territory	4
The approaches and challenges in the management of differentiated thyroid carcinoma	4
Biomarkers in gastroenteropancreatic neuroendocrine neoplasms	4
Glutamic acid decarboxylase immunotherapy for type 1 diabetes	4
Potassium-competitive acid blockers and acid-related disorders	4
Hypoparathyroidism update	4
Obesity during pregnancy: contemporary evidence and clinical implications	4
Editorial introductions	4
Prediabetes and skeletal health	4
Metabolic dysfunction and the use of adjunct medications in type 1 diabetes	4
Subclinical hyperthyroidism	4
Overview of diabetes agents in cardiovascular disease: it takes an orchestra to play Tchaikovsky in symphony	4
Cardiometabolic risk and therapeutic outcomes in mild autonomous cortisol secretion	4
Health effects of androgen abuse: a review of the HAARLEM study	3
Glucagon-like peptide-1 receptor agonists and safety in the preconception period	3
An update: maternal iodine supplementation, thyroid function tests, and child neurodevelopmental outcomes	3
Cardiovascular disease in metabolic-associated fatty liver disease	3
Parathyroid hormone assays in 2026: second versus third generation, standardization, and clinical interpretation	3
Emerging treatment for congenital adrenal hyperplasia	3
Differences in the management of thyroid nodules in children and adolescents as compared to adults	3
Editorial: Childhood endocrine and genetic disorders: improving adult outcomes	3
Better care for women with polycystic ovary syndrome – a proposal for an international evidence based best practice framework to improve care	3
The evolution of C-peptide's role in diabetes care	3
Adjunctive diabetes therapies and cardiovascular protection in type 1 diabetes: tackling the challenging Tchaikovsky piece	3
Mouse models of type 1 diabetes and their use in skeletal research	3
Update on management of paediatric dyslipidaemia	3
Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name?	3
Use of anti-Müllerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome	3
Editorial overview	2
Emerging concepts in the diagnosis and management of metabolically associated steatotic liver disease	2
Selective progesterone receptor modulators and reproductive health	2
Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?	2
Editorial introductions	2
Editorial introduction	2
Effects of diabetes on osteocytes	2
Eicosapentaenoic acid vs. docosahexaenoic acid for the prevention of cardiovascular disease	2
Editorial introductions	2
Use of calculated free testosterone in men: advantages and limitations	2
Obesity-related glomerulopathy: a lesser known complication of obesity	2
Effect of GLP-1 receptor agonists on body composition	2
Under and overtreatment with thyroid hormone replacement during pregnancy	2
Molecular testing for indeterminate thyroid nodules: past, present, and future	2
Editorial introductions	2
Editorial introduction	2
Current perspectives on biomarkers in metabolic bone disease	2
Effect of incretins on skeletal health	2
Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia	2
Molecular tools for diagnosing diseases of the adrenal cortex	2
An overview of persistent chylomicronemia: much more than meets the eye	2
Addressing genetic and environmental sources of cardiometabolic disease	2